Investments In The Digital Therapeutics Field Are Increasing To Drive IONM Market Growth Till 2025: Grand View Research,Inc.
The global digital therapeutics market is expected to reach
USD 9.3 billion by 2025, according to a new report by Grand View Research, Inc.
Digital therapeutics, known as software-as-a-drug, has undergone significant
developments, because of its cost-effectiveness and the potential to influence
human behavior - a challenge that is difficult to overcome in healthcare. A
shifting technological landscape worldwide has led to significant boost in
smartphone ownership and usage rates, which is anticipated to impact the market
positively. Other factors expected to influence growth of the market are rising
occurrence of chronic diseases, increasing attention on preventive healthcare
and an emerging need to control healthcare costs.
Digital therapeutics holds
exciting prospects in terms of unrealized potential. With a shift to
value-based, patient-centric healthcare system, and increasing reforms by the
government to cut down healthcare costs, it is anticipated that the market will
witness lucrative growth evident from a growing number of new startup companies
in the market. Although investments in the digital therapeutics field are
increasing, still application developers are dissuaded by the lack of
monetizing opportunities besides paid downloads and advertising. Furthermore, developing
countries are expected to have a lackluster response for digital therapeutics
due to lack of proper technological infrastructure and lack of adequate
research and development (R&D) and capital investments.
Browse full research report on Digital Therapeutics
Market: http://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market
Further key findings from
the study suggest:
- The diabetes segment has recorded strong growth owing
to rise in prevalence of diabetes from 108 million in 1980 to 422 million
in 2014, representing 8.5% of the population
- Obesity, another area of concern, has been
acknowledged as a risk factor for the occurrence of many chronic diseases,
such as osteoarthritis. Thus, the demand for health applications to
counter obesity is expected to be high
- North America is a leading market due to high
concentration of digital therapeutic companies in the region coupled with
high burden of chronic diseases
- Asia Pacific is expected to exhibit fastest growth
owing to a rapidly changing technological landscape and a huge target
population density
- Some of the major key players are Proteus Digital
Health, Inc.; Omada Health, Inc.; WellDoc, Inc.; 2Morrow, Inc.; Livongo
Health; Propeller Health; and Twine Health, Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the digital therapeutics
market on the basis of application, end use, and region:
Application Outlook (Revenue, USD Million; 2014 - 2025)
- Diabetes
- Obesity
- CVD
- CNS
Disease
- Respiratory
Diseases
- Smoking
Cessation
- Others
End Use Outlook (Revenue, USD Million; 2014 - 2025)
- Patients
- Providers
- Payers
- Employers
- Others
Regional Outlook (Revenue, USD Million; 2014- 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Saudi
Arabia
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment